HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account

Clinical Expertise

Monoclonal gammopathy bone disease. Dr. Drake is the program director and principal investigator (PI) on a study focused on the origins and development of monoclonal gammopathy bone disease, with funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Multiple myeloma. Dr. Drake led an investigation, funded by the Multiple Myeloma Research Foundation, aimed at better understanding how the disease causes bone destruction. He was also the PI on Mayo Clinic studies looking specifically at the molecular basis for bone destruction in multiple myeloma as well as bone microarchitecture in multiple myeloma, smoldering multiple myeloma, and monoclonal gammopathy of undetermined significance (MGUS).


Mayo Clinic Rochester: Gonda Building, 200 1st St SW, Rochester, MN 55905, USA

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube